Lansoprazole Ranbaxy (Uk)

Lansoprazole, the active ingredient in Lansoprazole Ranbaxy, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease. GNH USA supplies Lansoprazole Ranbaxy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that addresses conditions caused by excess gastric acid. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Erosive esophagitis: aids mucosal repair and reduces inflammation. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Lansoprazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: occasional loose stools. - Nausea: transient feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reactions. - Clostridioides difficile infection: severe colitis. - Severe liver injury: jaundice or hepatic dysfunction. - Anaphylaxis: life‑threatening allergic response. - Interstitial nephritis: kidney inflammation. - Bone fractures: increased risk with long‑term use.

Before initiating therapy, consider the following precautions: - Renal function assessment: adjust use in severe renal impairment. - Hepatic monitoring: evaluate liver function for prolonged treatment. - Long‑term use caution: monitor for increased risk of bone fractures. - Elderly patients: use the lowest effective dose and monitor for adverse effects. - Hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral efficacy. - HIV protease inhibitors (e.g., ritonavir): lowered plasma concentrations. - Methotrexate: increased toxicity risk. - Voriconazole: reduced antifungal activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR. - Digoxin: increased serum levels. - Phenytoin: reduced anticonvulsant effect. - Rifampin: decreased lansoprazole exposure. - Theophylline: possible increased plasma concentration.